代理出産の世界市場2016–2025:種類別(代理出産、代理母出産)、技術別

◆英語タイトル:Surrogacy Market by Type (Gestational Surrogacy and Traditional Surrogacy) and Technology (IVF with ICSI, IVF without ICSI, and IUI): Global Opportunity Analysis and Industry Forecast, 2016–2025
◆商品コード:AMR20SP025
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2020年7月
◆ページ数:134
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,769 ⇒換算¥634,590見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥709,500見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算¥989,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは代理出産の世界市場について詳細に調査・分析し、イントロダクション、エグゼクティブサマリー、市場概要、種類別(体外受精、顕微授精、子宮内受精)分析、技術別(IVF-ICSI、ICSI無しIVF)分析、地域別分析、企業情報など、今後の市場展望をまとめております。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・代理出産の世界市場規模:種類別(体外受精、顕微授精)
・代理出産の世界市場規模:技術別(IVF-ICSI、ICSI無しIVF、子宮内受精)
・代理出産の世界市場規模:地域別
・企業情報
【レポートの概要】

The global surrogacy market generated $112.80 million in 2015 and is projected to reach $201.40 million by 2025, growing at a CAGR of 6.1% from 2016 to 2025.
Surrogacy is a method of assisted reproduction in which the intended parents work with a surrogate who carries the baby until birth. There are two types of assisted reproductive procedures that are used for surrogacy, namely, traditional and gestational. Traditional technology involves utilization of surrogate’s eggs, making her biological mother of the baby. While in gestational, the surrogate does not have any type of biological link with the baby. In case of altruistic surrogacy, a surrogate does not receive any monetary compensation as majority of these agreements involve close relatives of the intended parents. The industry comprises both altruistic as well as commercial practice. In addition, commercial practice is restricted in majority of countries across the world.

The global surrogacy market is expected to witness a substantial growth in the future, owing to high incidences of infertility cases, emerging trend of delayed pregnancies among women, rise in technological advancements in fertility procedures, and increase in rate of gamete donations. Furthermore, rise in health awareness on fertility issues, availability of fertility treatments, increase in disposable income, and favorable reimbursement policies further augment the market growth.

The case of ‘Baby M’ in 1986 led to firmer surrogacy laws that led to adoption of gestational practice by several surrogacy professionals to avoid legal entanglements. However, these regulations did not have significant effect on the tindustry growth as the demand persisted to be constant. Technological advancements in assisted reproductive techniques, coupled with soaring cases of infertility is expected to drive the market growth during the forecast period. Moreover, rise in new fertility & surrogacy clinics and increase in same-sex marriages are projected to offer lucrative growth opportunities in for the market in the future. In addition, rise in fertility tourism is expected to provide ample growth opportunities, especially in developing economies. However, high cost related to the procedure along with stringent regulations pertaining to surrogacy in several countries are expected to restrict the growth of market.

The global surrogacy market is segmented on the basis of type, technology, end user, and region. By type, it is divided into gestational surrogacy and traditional surrogacy. By technology, it is segmented into IVF with intracytoplasmic sperm injection (ICSI), IVF without ICSI, and intrauterine insemination (IUI). Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global surrogacy market include New Hope Fertility Center, IVI RMA Global, Clinic Scanfert, Bourn Hall Fertility Clinic, NOVA IVI Fertility, Houston Fertility Center, Ovation Fertility, Extraordinary Conceptions, Care Fertility Group, Growing Generations LLC.

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the surrogacy market, and the current trends and future estimations to elucidate the imminent investment pockets.
• It presents a quantitative analysis of the market from 2015 to 2025 to enable stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
• Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS
By type
• Gestational surrogacy
• Traditional surrogacy

By Technology
• IVF with ICSI
• IUI
• IVF without ICSI

By Region
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific
• Japan
• China
• India
• Australia
• Rest of Asia-Pacific
LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• New Hope Fertility Center
• IVI RMA Global
• Clinic Scanfert
• Bourn Hall Fertility Clinic
• NOVA IVI Fertility
• Houston Fertility Center
• Ovation Fertility
• Extraordinary Conceptions
• Care Fertility Group
• Growing Generations LLC

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Market dynamics

3.2.1.Drivers

3.2.1.1.Increase in number of infertility cases globally
3.2.1.2.Alcohol consumption leading to infertility issues
3.2.1.3.Rise in awareness regarding infertility treatment options
3.2.1.4.Growth in prevalence of causative factors

3.2.2.Restraints

3.2.2.1.Impact of COVID-19 on the surrogacy market
3.2.2.2.Stringent regulations pertaining commercial surrogacy

3.2.3.Opportunity

3.2.3.1.Rise in fertility tourism

3.3.COVID-19 impact on the market

CHAPTER 4:SURROGACY MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast, by type
4.1.2.Market size and forecast, by type

4.2.Gestational Surrogacy

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region

4.3.Traditional Surrogacy

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market size and forecast, by region

CHAPTER 5:SURROGACY MARKET, BY TECHNOLOGY

5.1.Overview

5.1.1.Market size and forecast (Value)
5.1.2.Market size and forecast (volume)

5.2.IVF with ICSI

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region

5.3.IVF without ICSI

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region

5.4.Intrauterine Insemination

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region

CHAPTER 6:SURROGACY MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast, by region

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by technology

6.2.3.1.U.S. market size and forecast, by type
6.2.3.2.U.S. market size and forecast, by technology
6.2.3.3.Canada market size and forecast, by type
6.2.3.4.Canada market size and forecast, by technology
6.2.3.5.Mexico market size and forecast, by type
6.2.3.6.Mexico market size and forecast, by technology

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by type
6.3.3.Market size and forecast, by technology

6.3.3.1.UK market size and forecast, by type
6.3.3.2.UK market size and forecast, by technology
6.3.3.3.Rest of Europe market size and forecast, by type
6.3.3.4.Rest of Europe market size and forecast, by technology

6.4.Asia-pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by type
6.4.3.Market size and forecast, by technology

6.4.3.1.India market size and forecast, by type
6.4.3.2.India market size and forecast, by technology
6.4.3.3.Australia market size and forecast, by type
6.4.3.4.Australia market size and forecast, by technology
6.4.3.5.Rest of Asia-Pacific market size and forecast, by type
6.4.3.6.Rest of Asia-Pacific market size and forecast, by technology

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by type
6.5.3.Market size and forecast, by technology

6.5.3.1.Brazil market size and forecast, by type
6.5.3.2.Brazil market size and forecast, by technology
6.5.3.3.South Africa market size and forecast, by type
6.5.3.4.South Africa market size and forecast, by technology
6.5.3.5.Rest of LAMEA market size and forecast, by type
6.5.3.6.Rest of LAMEA market size and forecast, by technology

CHAPTER 7:COMPANY PROFILES

7.1.NEW HOPE FERTILITY CLINIC

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments

7.2.IVI RMA GLOBAL

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments

7.3.HOUSTON FERTILITY CENTER

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments

7.4.CLINIC SCANFERT

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments

7.5.BOURN HALL FERTILITY CLINIC

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments

7.6.NOVA IVI FERTILITY

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments

7.7.OVATION FERTILITY

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments

7.8.EXTRAORDINARY CONCEPTIONS

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments

7.9.CARE FERTILITY GROUP

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments

7.10.GROWING GENERATIONS LLC

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments

LIST OF TABLES

TABLE 01.GLOBAL SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 02.GLOBAL SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 03.SURROGACY MARKET FOR GESTATIONAL SURROGACY, BY REGION, 2016–2025 ($MILLION)
TABLE 04.SURROGACY MARKET FOR GESTATIONAL SURROGACY, BY REGION, 2016–2025 (NO. OF CYCLES)
TABLE 05.SURROGACY MARKET FOR TRADITIONAL SURROGACY, BY REGION, 2016–2025 ($MILLION)
TABLE 06.SURROGACY MARKET FOR TRADITIONAL SURROGACY, BY REGION, 2016–2025 (NO. OF CYCLES)
TABLE 07.GLOBAL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 08.GLOBAL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 09.SURROGACY MARKET FOR IVF WITH ICSI, BY REGION, 2015–2025 ($MILLION)
TABLE 10.SURROGACY MARKET FOR IVF WITH ICSI, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 11.SURROGACY MARKET FOR IVF WITHOUT ICSI, BY REGION, 2015–2025 ($MILLION)
TABLE 12.SURROGACY MARKET FOR IVF WITHOUT ICSI, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 13.SURROGACY MARKET FOR IUI, BY REGION, 2015–2025 ($MILLION)
TABLE 14.SURROGACY MARKET FOR IVF WITHOUT ICSI, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 15.GLOBAL SURROGACY MARKET, BY REGION, 2015–2025 ($MILLION)
TABLE 16.GLOBAL SURROGACY MARKET, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 17.NORTH AMERICA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 18.GLOBAL SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 19.NORTH AMERICA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 20.GLOBAL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 21.U.S. SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 22.U.S. SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 23.U.S. SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 24.U.S. SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 25.CANADA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 26.CANADA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 27.CANADA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 28.CANADA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 29.MEXICO SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 30.MEXICO SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 31.MEXICO SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 32.MEXICO SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 33.EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 34.EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 35.EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 36.EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 37.UK SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 38.UK SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 39.UK SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 40.UK SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 41.REST OF EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 42.REST OF EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 (NO.OF CYCLES)
TABLE 43.REST OF EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 44.REST OF EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 45.ASIA PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 46.ASIA PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 47.ASIA PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 48.ASIA PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 49.INDIA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 50.INDIA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 51.INDIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 52.INDIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 53.AUSTRALIA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 54.AUSTRALIA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 55.AUSTRALIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 56.AUSTRALIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 57.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 58.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 59.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 60.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 61.LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 62.LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 63.LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 64.LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 65.BRAZIL SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 66.BRAZIL SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 67.BRAZIL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 68.BRAZIL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 69.SOUTH AFRICA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 70.SOUTH AFRICA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 71.SOUTH AFRICA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 72.SOUTH AFRICA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 73.REST OF LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 74.REST OF LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 75.REST OF LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 76.REST OF LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 77.NHFC: COMPANY SNAPSHOT
TABLE 78.NHFC: PRODUCT SEGMENTS
TABLE 79.RMA: COMPANY SNAPSHOT
TABLE 80.RMA: SERVICE SEGMENTS
TABLE 81.HOUSTON FERTILITY CENTER: COMPANY SNAPSHOT
TABLE 82.HOUSTON FERTILITY CENTER: OPERATING SEGMENTS
TABLE 83.CLINIC SCANFERT: COMPANY SNAPSHOT
TABLE 84.CLINIC SCANFERT: OPERATING SEGMENTS
TABLE 85.BOURN HALL FERTILITY CLINIC: COMPANY SNAPSHOT
TABLE 86.BOURN HALL FERTILITY CLINIC: PRODUCT SEGMENTS
TABLE 87.NOVA IVI FERTILITY: COMPANY SNAPSHOT
TABLE 88.NOVA IVI FERTILITY: OPERATING SEGMENTS
TABLE 89.OVATION: COMPANY SNAPSHOT
TABLE 90.OVATION: PRODUCT SEGMENTS
TABLE 91.EXTRAORDINARY CONCEPTIONS: COMPANY SNAPSHOT
TABLE 92.EXTRAORDINARY CONCEPTIONS: PRODUCT SEGMENTS
TABLE 93.CARE FERTILITY GROUP: COMPANY SNAPSHOT
TABLE 94.CARE FERTILITY GROUP: OPERATING SEGMENTS
TABLE 95.GROWING GENERATIONS LLC: COMPANY SNAPSHOT
TABLE 96.GROWING GENERATIONS LLC: SERVICES

LIST OF FIGURES

FIGURE 01.SURROGACY MARKET: MARKET SEGMENTATION
FIGURE 02.MARKET DYNAMICS

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[代理出産の世界市場2016–2025:種類別(代理出産、代理母出産)、技術別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆